Title: Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
Authors: Regan, Meredith M ×
Neven, Patrick
Giobbie-Hurder, Anita
Goldhirsch, Aron
Ejlertsen, Bent
Mauriac, Louis
Forbes, John F
Smith, Ian
Láng, István
Wardley, Andrew
Rabaglio, Manuela
Price, Karen N
Gelber, Richard D
Coates, Alan S
Thürlimann, Beat
Smeets, Ann
BIG 1-98 Collaborative Group
International Breast Cancer Study Group (IBCSG) #
Issue Date: Nov-2011
Publisher: Lancet Pub. Group
Series Title: The Lancet Oncology vol:12 issue:12 pages:1101-8
Abstract: Postmenopausal women with hormone receptor-positive early breast cancer have persistent, long-term risk of breast-cancer recurrence and death. Therefore, trials assessing endocrine therapies for this patient population need extended follow-up. We present an update of efficacy outcomes in the Breast International Group (BIG) 1-98 study at 8·1 years median follow-up.
ISSN: 1470-2045
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Surgical Oncology
Gynaecological Oncology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science